These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16764702

  • 1. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
    Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.
    Scand J Immunol; 2006 Jun; 63(6):478-86. PubMed ID: 16764702
    [Abstract] [Full Text] [Related]

  • 2. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
    Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.
    Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
    [Abstract] [Full Text] [Related]

  • 3. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
    Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB.
    J Med Virol; 2008 Feb; 80(2):209-16. PubMed ID: 18098145
    [Abstract] [Full Text] [Related]

  • 4. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C, Alberola J, Tamarit A, Navarro D.
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [Abstract] [Full Text] [Related]

  • 5. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 6. Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.
    Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H.
    J Acquir Immune Defic Syndr; 2004 Apr 01; 35(4):337-42. PubMed ID: 15097149
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients.
    Lomholt AF, Christensen IJ, Høyer-Hansen G, Nielsen HJ.
    Acta Oncol; 2010 Aug 01; 49(6):805-11. PubMed ID: 20524776
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
    Begum FD, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Høyer-Hansen G, Ring-Larsen H, Høgdall EV.
    Anticancer Res; 2004 Aug 01; 24(3b):1981-5. PubMed ID: 15274388
    [Abstract] [Full Text] [Related]

  • 9. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
    Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N.
    Ann Neurol; 2004 May 01; 55(5):687-94. PubMed ID: 15122709
    [Abstract] [Full Text] [Related]

  • 10. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis.
    Domingo P, Vidal F, Domingo JC, Veloso S, Sambeat MA, Torres F, Sirvent JJ, Vendrell J, Matias-Guiu X, Richart C, HIV-FRS Study Group.
    Eur J Clin Invest; 2005 Dec 01; 35(12):771-80. PubMed ID: 16313254
    [Abstract] [Full Text] [Related]

  • 11. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R, Stephens RW, Brünner N, Christensen IJ, Nielsen HJ, Heilmann L, von Tempelhoff GF.
    Gynecol Oncol; 2001 Sep 01; 82(3):523-31. PubMed ID: 11520150
    [Abstract] [Full Text] [Related]

  • 12. Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
    Henic E, Borgfeldt C, Christensen IJ, Casslén B, Høyer-Hansen G.
    Clin Cancer Res; 2008 Sep 15; 14(18):5785-93. PubMed ID: 18794088
    [Abstract] [Full Text] [Related]

  • 13. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
    Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, Gomes VF, Lisse I.
    Int J Tuberc Lung Dis; 2002 Aug 15; 6(8):686-92. PubMed ID: 12150480
    [Abstract] [Full Text] [Related]

  • 14. Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability.
    Olson FJ, Thurison T, Ryndel M, Høyer-Hansen G, Fagerberg B.
    Clin Biochem; 2010 Jan 15; 43(1-2):124-30. PubMed ID: 19822140
    [Abstract] [Full Text] [Related]

  • 15. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Jan 15; 119(4):475-80. PubMed ID: 16828495
    [Abstract] [Full Text] [Related]

  • 16. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
    Mustjoki S, Sidenius N, Sier CF, Blasi F, Elonen E, Alitalo R, Vaheri A.
    Cancer Res; 2000 Dec 15; 60(24):7126-32. PubMed ID: 11156421
    [Abstract] [Full Text] [Related]

  • 17. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G, Contini P, Setti M, Cagnati P, Villa R, Lantieri F, Indiveri F, Puppo F.
    Hum Immunol; 2007 Nov 15; 68(11):894-900. PubMed ID: 18082568
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 19. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.
    Schindler K, Haider D, Wolzt M, Rieger A, Gmeinhart B, Luger A, Nowotny P, Ludvik B.
    Eur J Clin Invest; 2006 Sep 15; 36(9):640-6. PubMed ID: 16919047
    [Abstract] [Full Text] [Related]

  • 20. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
    Wittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen SS, Eugen-Olsen J.
    Clin Microbiol Infect; 2004 May 15; 10(5):409-15. PubMed ID: 15113317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.